Parwani, Purvi http://orcid.org/0000-0002-4707-992X
Kang, Nicolas
Safaeipour, Mary
Mamas, Mamas A.
Wei, Janet
Gulati, Martha
Naidu, Srihari S.
Merz, Noel Bairey
Funding for this research was provided by:
Loma Linda University
Article History
Accepted: 30 March 2023
First Online: 17 April 2023
Compliance with Ethical Standards
:
: NBM receives consulting fees from iRhythm and SHL Telemedicine. MG served on an advisory board for Novartis and was a speaker for Siemens Healthcare Diagnostics. She is a co-investigator and site PI of the Women’s Ischemia Trial to Reduce Events In Non-Obstructive CAD (WARRIOR) Study funded by the Department of Defense (Award Number: W81XWH-17–2-0030) and a co-investigator of the Women Ischemic Syndrome Evaluation (WISE) Study funded by the NHLBI. She is also the president of the American Society for Preventive Cardiology (unpaid). JW served on an advisory board for Abbott Vascular (paid to institution). PP received payment or honoraria from AstraZeneca and participated on a Data Safety Monitoring Board or Advisory Board for Medtronic.
: This article does not contain any studies with human or animal subjects performed by any of the authors.